Total Payments
$11,155
2024 Payments
$1,272
Companies
55
Transactions
794
Medicare Patients
10,167
Medicare Billing
$569,092
Payment Breakdown by Category
Food & Beverage$11,146 (99.9%)
Education$8.35 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,146 | 793 | 99.9% |
| Education | $8.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,931 | 148 | $0 (2024) |
| Novo Nordisk Inc | $1,382 | 110 | $0 (2024) |
| Lilly USA, LLC | $1,322 | 104 | $0 (2024) |
| Amgen Inc. | $1,165 | 77 | $0 (2024) |
| PFIZER INC. | $762.95 | 85 | $0 (2024) |
| Merck Sharp & Dohme LLC | $394.50 | 22 | $0 (2022) |
| PREVENTRIC DIAGNOSTICS, INC. | $383.37 | 1 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $345.53 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $308.47 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $296.41 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,272 | 82 | ABBVIE INC. ($447.50) |
| 2023 | $1,587 | 107 | AbbVie Inc. ($524.66) |
| 2022 | $2,126 | 146 | ABBVIE INC. ($645.07) |
| 2021 | $2,003 | 113 | PREVENTRIC DIAGNOSTICS, INC. ($383.37) |
| 2020 | $760.68 | 57 | Lilly USA, LLC ($167.55) |
| 2019 | $1,325 | 117 | Amgen Inc. ($347.81) |
| 2018 | $907.82 | 77 | Amgen Inc. ($243.93) |
| 2017 | $1,172 | 95 | PFIZER INC. ($166.46) |
All Payment Transactions
794 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CNS | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Obesity | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Biological | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Obesity | ||||||
| 09/19/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $73.74 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,125 | 4,596 | $250,664 | $113,977 |
| 2022 | 45 | 2,465 | 5,082 | $266,357 | $128,557 |
| 2021 | 44 | 2,624 | 5,993 | $336,007 | $161,864 |
| 2020 | 49 | 2,953 | 6,737 | $378,703 | $164,694 |
Total Patients
10,167
Total Services
22,408
Medicare Billing
$569,092
Procedure Codes
179
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 355 | $80,355 | $29,049 | 36.2% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 95 | 257 | $20,210 | $10,488 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $13,860 | $8,214 | 59.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 67 | 186 | $15,810 | $7,448 | 47.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 20 | 78 | $9,360 | $4,585 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 86 | 241 | $7,230 | $3,967 | 54.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 68 | 136 | $8,296 | $3,916 | 47.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 95 | 261 | $7,308 | $3,374 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 27 | $7,446 | $2,695 | 36.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 93 | 260 | $4,680 | $2,691 | 57.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 13 | 21 | $4,155 | $2,355 | 56.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 245 | $4,410 | $2,305 | 52.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 267 | $2,937 | $2,234 | 76.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 95 | 264 | $3,696 | $2,005 | 54.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 41 | 82 | $3,116 | $1,903 | 61.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 45 | 119 | $3,332 | $1,759 | 52.8% |
| 83735 | Magnesium level | Office | 2023 | 96 | 266 | $3,990 | $1,729 | 43.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 69 | 69 | $3,318 | $1,726 | 52.0% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 67 | 69 | $4,658 | $1,719 | 36.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 65 | 69 | $4,830 | $1,718 | 35.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 44 | 118 | $2,950 | $1,700 | 57.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 19 | 20 | $5,900 | $1,671 | 28.3% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 42 | 108 | $2,700 | $1,501 | 55.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 40 | 108 | $2,700 | $1,443 | 53.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 74 | 74 | $2,522 | $1,288 | 51.1% |
About Dr. Karla Smith, MD
Dr. Karla Smith, MD is a Pain Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275663593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karla Smith, MD has received a total of $11,155 in payments from pharmaceutical and medical device companies, with $1,272 received in 2024. These payments were reported across 794 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,146).
As a Medicare-enrolled provider, Smith has provided services to 10,167 Medicare beneficiaries, totaling 22,408 services with total Medicare billing of $569,092. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Family Medicine
- Location High Point, NC
- Active Since 03/06/2007
- Last Updated 08/05/2025
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1275663593
Products in Payments
- UBRELVY (Drug) $760.93
- QULIPTA (Drug) $722.75
- Aimovig (Biological) $680.63
- Ozempic (Drug) $621.94
- MOUNJARO (Drug) $460.27
- TRULICITY (Drug) $431.95
- JARDIANCE (Drug) $388.52
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $383.37
- Kerendia (Drug) $345.53
- CHANTIX (Drug) $304.94
- NURTEC ODT (Drug) $284.44
- Saxenda (Drug) $255.11
- Rybelsus (Drug) $248.50
- FARXIGA (Drug) $237.75
- VRAYLAR (Drug) $229.13
- Prolia (Biological) $199.35
- EMGALITY (Drug) $186.48
- Xofluza (Drug) $179.87
- BELSOMRA (Drug) $176.76
- ELIQUIS (Drug) $176.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in High Point
Hilary Brownstead, Md, MD
Pain Medicine — Payments: $42,542
Pain Medicine $42,542
Moogali Arvind, M.d, M.D
Pain Medicine — Payments: $18,244
Pain Medicine $18,244
Dr. Janus Patel, M.d, M.D
Pain Medicine — Payments: $11,541
Pain Medicine $11,541
Eric Moser, Md, MD
Pain Medicine — Payments: $5,030
Pain Medicine $5,030
Melissa Shelton
Pain Medicine — Payments: $4,048
Pain Medicine $4,048
Krishnamani Chinnasamy, M.d, M.D
Pain Medicine — Payments: $2,911
Pain Medicine $2,911